New drug shows promise for Hard-to-Treat breast cancers

NCT ID NCT05461768

First seen Oct 31, 2025 · Last updated May 12, 2026 · Updated 24 times

Summary

This early-stage trial tests a new drug, BL-M07D1, in people with advanced breast cancer or other solid tumors that have a specific protein called HER2. The study aims to find a safe dose and check for side effects. About 26 adults whose cancer has not responded to standard treatments will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dongguan People's Hospital

    RECRUITING

    Dongguan, Guangdong, China

    Contact

    Contact

    Contact

  • Fujian Cancer Hospital

    RECRUITING

    Fuzhou, Fujian, China

    Contact

  • Jinan Central Hospital

    RECRUITING

    Jinan, Shandong, China

    Contact

    Contact

    Contact

  • Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    RECRUITING

    Guangdong, Guangzhou, 510120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, China

    Contact

  • Zhongnan Hospital of Wuhan University

    RECRUITING

    Wuhan, Hubei, China

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.